The Food and Drug Administration is seeking comments by June 11, 2014 on its review for Olaparib approval. Olaparib is an oral poly ADP-ribose polymerase (PARP) inhibitor that exploits DNA … Continued
(May 16, 2014) Breastfeeding, tubal ligation – also known as having one’s “tubes tied” – and oral contraceptives may lower the risk of ovarian cancer for some women with BRCA … Continued
Despite recommendations from the federal government that women at high-risk of developing breast and ovarian cancer be offered genetic counseling and testing at no out of pocket cost, a new … Continued
(May 6, 2014) Tumors use numerous mechanisms to escape detection and killing by the immune system. Results from OCRF-funded research, reported May 4, 2014 in the prestigious journal Nature Medicine, … Continued
This week, the Ovarian Cancer National Alliance submitted comments to the Food and Drug Administration (FDA) about a proposed Guidance for Industry that could have the effect of limiting patient … Continued
(April 30, 2014) A positive pretreatment imaging test more than doubled the likelihood of disease control in platinum-resistant advanced ovarian cancer treated with the folate receptor-targeted drug vintafolide (trade name … Continued
Rhonda’s Club was founded in 1997, roughly the same time as the Ovarian Cancer National Alliance—and by some of the same people. Rhonda Oziel, Pat Goldman, Ann Kolker, Clare Donelan … Continued
With two marquee scientific conferences, the Society for Gynecologic Oncology (SGO) and the American Association for Cancer Research (AACR), occurring back-to-back, the past few weeks have seen an explosion in … Continued
This month, we celebrate Liz Tilberis, beloved former president of OCRF and editor-in-chief of Harper's Bazaar.
(April 15, 2014) Prolonged (>35 days), infrequent, or anovulatory menstrual cycles was associated with as much as a two-fold increase in ovarian cancer and more than a three-fold increase in … Continued
(April 8, 2014) A team of researchers have found that vigorous physical activity prior to ovarian cancer diagnosis was associated with a lower risk of ovarian cancer mortality. The findings … Continued
Designer Charity Sale expands to the West Coast in celebration of OCRF’S 20th Anniversary; Offers Day-Long Luxury Experiences for the Whole Family Los Angeles, CA (April 7, 2014) – Rachel … Continued
Get email updates about research news, action alerts, and ways to join the fight.
